Clinical Trial

Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
A portion of patients with Inflammatory bowel disease often require surgical intervention since they do not respond to the current therapies. Besides this risk, patients may develop post-operative disease complications, and the factors beneath are far from being understood or predicted. The investigators hypothesize that some priming factors remain in the resection margin after surgery and act as a memory of the evolution of the disease, leading to the recurrence or complications. The following proposals are made: 1. defining and validating in humanized experimental models of intestinal inflammation the spatial and temporal dynamics of the postoperative complications-priming factors 2. integrating them into a machine-learning-driven model to determine risk indices of disease recurrence in IBD patients. This risk prediction model will not change the clinical decision-making process but will only be built for research. Consequently, patients enrolled in this study will be monitored and treated as per the standard of care. This project will reveal possible causes and build methods predictive of postoperative complications ultimately resulting in changes in clinical management in the near future.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-18.
Status change: Not Yet Recruiting → Recruiting 2025-03-11
Trial Details
NCT Number NCT06516341
Lead Sponsor IRCCS Ospedale San Raffaele
Collaborators: IRCCS Casa Sollievo della Sofferenza, Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona, Ministero della Salute, Italy
Conditions Ulcerative Colitis, Crohn Disease
Enrollment 35 participants
Start Date 2025-02-27
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-03-14